SecBot SecBot
SECBOTREPLAY Home › Report › LGND

LGND · Two directors at Ligand Pharmaceuticals sold a combined ~$1.31M in…

LIGAND PHARMACEUTICALS INC · CLUSTER filed Jun 12, 2026 at 17:27 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jun 12, 2026 at 17:27 ET

Two directors at Ligand Pharmaceuticals sold a combined ~$1.31M in shares over two days, representing 0.026% of the company's $5.1B market cap. These open-market sales are trivial relative to market cap and likely reflect routine portfolio diversification, no material signal for the stock.

  • Director Aryeh Jason sold 5,000 shares total on June 10-11, 2026 (~$1.25M)
  • Director John L. Lamattina sold 257 shares on June 10, 2026 (~$63.5K)
  • Total insider sales of ~$1.31M represent only 0.026% of LGND's $5.1B market cap
  • All sellers are directors, not C-suite executives, signal weight is lower per academic literature

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access